Abeona Therapeutics Inc. (ABEO) Fundamentals

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases.
SHARE INFORMATION
Market Cap$ 48,435,753
Shares Outstanding17,175,799
Float17,102,314
Percent Float99.57%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 3,000,000
Latest Fiscal EPS$ -21.55
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions90
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months543,996
Institutional Holdings Percent12.5%
Institutional Sold Previous 3 Months587,781
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months15,869
Insider Holdings Percent20.8
Insider Sold Previous 3 Months207
Insider Shares Owned3,566,181
TRADING INFO
52 Week High$ 9.36
52 Week Low$ 2.34
52 Week High Change$ -55.85
21 Day Moving Average$ 2.7286
21 Day Extended Moving Average$ 2.7072
50 Day Moving Average$ 3.0106
50 Day Extended Moving Average$ 2.9885
200 Day Moving Average$ 3.9516
200 Day Extended Moving Average$ 5.5284
10 Day Average Volume160,384
20 Day Average Volume254,280
30 Day Average Volume292,619
50 Day Average Volume268,078
Alpha-0.058072
Beta1.1849
Standard Deviation0.245232
R20.068105
7 Day Price Change$ 0.20
7 Day Percent Change7.63%
21 Day Price Change$ 0.17
21 Day Percent Change6.42%
30 Day Price Change$ -0.26
30 Day Percent Change-8.44%
Month to Date Price Change$ 0.30
Month to Date Percent Change11.9%
Quarter to Date Price Change$ -0.26
Quarter to Date Percent Change-8.44%
180 Day Price Change$ -1.09
180 Day Percent Change-27.88%
200 Day Price Change$ -2.03
200 Day Percent Change-41.86%
Year to Date Price Change$ -0.26
Year to Date Percent Change-8.44%

Abeona Therapeutics Inc. (ABEO) Key Ratios

PROFITABILITY
EBIT Margin-1,947.3%
EBITDA Margin-1,837.6%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin92.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 1,346,000
Revenue Per Share$ 0.0784
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book3.00
Total Debt To Equity0.50
Int Coverage-135.40
Current Ratio2.00
Leverage Ratio2.10
Quick Ratio1.50
Long Term Debt To Capital0.30
VALUATION MEASURES
PE Ratio-0.10
Enterprise Value$ 35,642,867
Price to Sales35.985
Price to Free Cash-1.50
PE High Last 5 Years-2.90
Price To Book3.00
Price To Cash Flow30.00
PE Low Last 5 Years-9.50
Price to Tangible Book3.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.70
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-112.86
Return on Equity-187.13
Return on Capital-161.56

Abeona Therapeutics Inc. (ABEO) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorWhitley Penn LLP
CEOVishwas Seshadri
Emplyoees90
Last AuditUQ
CIK0000318306
IndustryBiotechnology
SectorHealthcare
NAICSIn-Vitro Diagnostic Substance Manufacturing(325413)
CONTACT INFO
Address1330 Avenue of the Americas
33rd Floor
New York, NY 10019
Websitehttp://www.abeonatherapeutics.com
Facsimile-
Telephone+1 646 813-4701
Emailggin@abeonatherapeutics.com
Your Recent History
NASDAQ
ABEO
Abeona The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20230205 15:14:55